Research
July 14, 2021
NIH Awards $1.36 million Grant to Aid UAMS Research on Pregnant Women’s Pelvic Floor Muscles
The National Institutes of Health has awarded a $1.36 million grant to researchers at UAMS to develop a non-invasive means of detecting weaknesses in a pregnant woman’s pelvic floor muscles that could lead to injury while giving birth.
July 9, 2021
UAMS Medical Student Published in JAMA Network Open
The Journal of the American Medical Association (JAMA) recently published University of Arkansas for Medical Sciences (UAMS) medical student Austin Morgan’s results from his study on diversity among cancer centers’ leadership.
July 7, 2021
Researcher Finds Challenges in Study Involving Methamphetamine
If the photo of the pile of crystal methamphetamine doesn’t get your attention, the question on the flyer, designed by the UAMS Translational Research Institute and complete with the UAMS logo and familiar triangles, will.
“Use meth?”
July 6, 2021
Winthrop P. Rockefeller Cancer Institute Hosts First Summer Research Intensive for Medical Students
New discoveries in cancer treatment might come from 24-year-old Nadia Safar, one of 12 UAMS medical students participating in the state’s first and only undergraduate cancer research program at the Winthrop P. Rockefeller Cancer Institute.
July 1, 2021
UAMS Neurologist Co-Authors Best Practices Paper for Treating 2 Parkinson’s-related Disorders
LITTLE ROCK — A neurologist at the University of Arkansas for Medical Sciences (UAMS) has co-authored a paper in a leading neurology journal that provides the first best-practices consensus for treating two rare Parkinson’s-related disorders. Rohit Dhall, M.D., a professor of neurology in the College of Medicine and director of neurodegenerative disorders at UAMS, was…
June 29, 2021
UAMS Physicians See Dramatic Increase In Postpartum Psychosis Cases during COVID-19 Pandemic
LITTLE ROCK — Postpartum psychosis is a serious, albeit rare illness, compared to the number of postpartum depression cases seen in the United States.
June 24, 2021
UAMS’ First Phase 1 Cancer Clinical Trial Testing New Way to Protect Hearts while Treating Cancer
LITTLE ROCK — The drug dexrazoxane has a reputation akin to someone who both fights and sets fires. On the one hand, this Food and Drug Administration (FDA)-approved drug prevents heart damage caused by doxorubicin, which is used in chemotherapy. On the other hand, dexrazoxane may undermine the cancer treatment, causing many doctors to leave…
June 14, 2021
UAMS Project Part of National Effort to Reduce COVID-19 in Hardest Hit Populations
LITTLE ROCK — UAMS researchers and their community partners across Arkansas are studying the causes behind COVID-19’s devastating impact on minorities and developing plans to help increase vaccination rates.
June 4, 2021
Arkansas College Students Learn About COVID-19, Other Infectious Diseases at UAMS-led Workshop
UAMS treated Arkansas college students interested in research or medical careers involving infectious diseases like COVID-19 to a workshop May 19.
June 3, 2021
UAMS Donald W. Reynolds Institute on Aging Receives $1.9 Million Grant to Research Link Between Blood Sugar, Alzheimer’s Disease
The Donald W. Reynolds Institute on Aging at the University of Arkansas for Medical Sciences (UAMS) has been awarded a five-year, $1.9 million grant from the National Institute on Aging, a division of the National Institutes of Health.
Previous page Next page